Keyphrases
Alzheimer's Disease
100%
Orexin Receptors
100%
Neuroprotective Effect
100%
Heterodimerization
100%
GPR103
100%
Orexin
75%
Neuropeptides
50%
Orexigenic
50%
Plaque Formation
25%
Early Alzheimer's Disease
25%
Disease Onset
25%
Alzheimer's Disease Patient
25%
Familial Alzheimer's Disease
25%
Late-onset
25%
Cornu Ammonis
25%
In Vitro Model
25%
Weight Loss
25%
Signaling Pathway
25%
Patient Experience
25%
Pathophysiology
25%
Pharmacological Intervention
25%
Neuroprotective
25%
Neuroprotective Role
25%
Hetero
25%
Novel Therapeutics
25%
Feeding Behavior
25%
Conclusive Evidence
25%
Sleep-wake Cycle
25%
Exact Expression
25%
ERK1
25%
Energy Homeostasis
25%
Energy Regulation
25%
Transcriptomics
25%
Excessive Daytime Sleepiness
25%
Physiological Action
25%
Nocturnal Activity
25%
Tau Hyperphosphorylation
25%
Neuroscience
Alzheimer's Disease
100%
Neuroprotective Agent
100%
Orexin Receptor
100%
Orexin
75%
Familial Alzheimer's Disease
50%
Neuropeptide
50%
Orexigenic
50%
In Vitro
25%
Receptor
25%
Mitogen Activated Protein Kinase 3
25%
Transcriptomics
25%
Hyperphosphorylation
25%
Sleep Waking Cycle
25%
Feeding Behavior
25%
Daytime Somnolence
25%
Biochemistry, Genetics and Molecular Biology
Orexin
100%
Orexin Receptor
100%
Downregulation
66%
Neuropeptide
66%
Hyperphosphorylation
33%
Tau
33%
Fluorescence Resonance Energy Transfer
33%
Transcriptomics
33%
Sleep Waking Cycle
33%
Daytime Somnolence
33%
Homeostasis and Regulation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Neuroprotective Agent
100%
Orexin Receptor
100%
Orexin
50%
Neuropeptide
33%
Diseases
33%
Receptor
16%
Pathophysiology
16%
Heterodimer
16%
Mitogen Activated Protein Kinase 3
16%
Daytime Somnolence
16%